These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7005333)

  • 21. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
    [No Abstract]   [Full Text] [Related]  

  • 22. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosynthesis of macrophage activation factor.
    Baliga BS; Rorher SD; Maumenee AE; Peterson RD
    Lymphokine Res; 1986; 5(2):141-56. PubMed ID: 3517510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages in resistance to rickettsial infections: protection against lethal Rickettsia tsutsugamushi infections by treatment of mice with macrophage-activating agents.
    Nacy CA; Meltzer MS
    J Leukoc Biol; 1984 Apr; 35(4):385-96. PubMed ID: 6584528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro effect of mitogen-activated speen cells and their culture supernatants on mouse peritoneal macrophages as assayed by intracellular killing of Listeria monocytogenes and content of beta-galactosidase.
    Pedersen JK; Bennedsen J; Rhodes JM; Larsen SO
    J Reticuloendothel Soc; 1979 May; 25(5):469-77. PubMed ID: 110928
    [No Abstract]   [Full Text] [Related]  

  • 26. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophages in resistance to rickettsial infection: strains of mice susceptible to the lethal effects of Rickettsia akari show defective macrophage Rickettsicidal activity in vitro.
    Nacy CA; Meltzer MS
    Infect Immun; 1982 Jun; 36(3):1096-101. PubMed ID: 7047390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphokine-induced secretion of plasminogen activator by murine macrophages.
    Klimetzek V; Sorg C
    Eur J Immunol; 1977 Mar; 7(3):185-7. PubMed ID: 862658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophages in resistance to rickettsial infections: genetic analysis of susceptibility to lethal effects of Rickettsia akari infection and development of activated, cytotoxic macrophages in A and B10.a mice.
    Meltzer MS; Nacy CA; Stevenson MM; Skamene E
    J Immunol; 1982 Oct; 129(4):1719-23. PubMed ID: 6896718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
    Meltzer MS
    J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741
    [No Abstract]   [Full Text] [Related]  

  • 32. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages in resistance to rickettsial infections: early host defense mechanisms in experimental scrub typhus.
    Nacy CA; Groves MG
    Infect Immun; 1981 Mar; 31(3):1239-50. PubMed ID: 6785240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective Fc receptor-mediated phagocytosis in C3H/HeJ macrophages. I. Correction by lymphokine-induced stimulation.
    Vogel SN; Rosenstreich DL
    J Immunol; 1979 Dec; 123(6):2842-50. PubMed ID: 501093
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of migration inhibiting factor(s) on the in vitro detachment of macrophages.
    Weiss L; Glaves D
    J Immunol; 1975 Nov; 115(5):1362-5. PubMed ID: 1100729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
    Sone S; Poste G; Fidler IJ
    J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages.
    Byrne GI; Faubion CL
    J Immunol; 1982 Jan; 128(1):469-74. PubMed ID: 7054284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S; Fidler IJ
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
    Geczy CL; Hopper KE
    J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.